Recent developments in myeloid immune modulation in cancer therapy

Area of Science:

• Immunology
• Oncology
• Cancer Biology

Background:

• Myeloid cells critically influence cancer progression, immune suppression, and metastasis.
• Their dual role presents a therapeutic challenge and opportunity in oncology.
• Modulating myeloid cell function is key to enhancing antitumor immunity.

Purpose of the Study:

• To review recent clinical strategies targeting tumor myeloid cells.
• To focus on reprogramming myeloid cells to promote antitumor immunity.
• To discuss methods for shifting myeloid cell function from tumor promotion to immune support.

Main Methods:

• Review of current therapeutic approaches targeting myeloid cell numbers, genetics, metabolism, and tumor microenvironment interactions.
• Analysis of strategies inhibiting immunosuppressive pathways and targeting specific receptors.
• Examination of methods promoting differentiation into less immunosuppressive phenotypes.

Main Results:

• Therapeutic strategies are being developed to reprogram myeloid cells within the tumor microenvironment.
• Approaches focus on reversing immunosuppressive functions and redirecting myeloid cells to support anti-cancer immunity.
• Clinical targeting aims to modify myeloid cell behavior for improved therapeutic outcomes.

Conclusions:

• Reprogramming tumor myeloid cells is a promising strategy to enhance antitumor immunity.
• Targeting myeloid cell function offers a novel therapeutic avenue in cancer treatment.
• Further research into clinical approaches for myeloid cell modulation is warranted.